Incanthera

NCT01023048

Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)

NCT01197872

Clinical Use of Parental Support To Detect Single Gene Mutations

NCT01574781

Non-invasive Prenatal Diagnostic Validation Study

NCT01545674

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial

NCT01546324

Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing

NCT01663584

Multi-disease Carrier Screening Test Validation

NCT02109770

Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA

NCT01852708

Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood

NCT02278536

Multiple Gestation Study

NCT01966991

Prenatal Screening for Down Syndrome With DNAFirst

NCT02278874

High Risk Multiple Gestation Study

NCT02381457

SNP-based Microdeletion and Aneuploidy RegisTry (SMART)

NCT03485651

Natera Ovarian Cancer Detection Assay

NCT03984747

Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection

NCT03765203

Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients

NCT04091984

The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)

NCT04239703

Trifecta-Kidney cfDNA-MMDx Study

NCT04264702

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

NCT04561453

Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

NCT05736523

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

NCT04761783

BESPOKE Study of ctDNA Guided Immunotherapy

NCT04707872

Trifecta-Heart cfDNA-MMDx Study

NCT05846113

Renasight Clinical Application, Review and Evaluation (RenaCARE) Study

NCT05004337

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

NCT05081024

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

NCT05205551

Prospera Test Evaluation in Cardiac Transplant (ProTECT)

NCT05312814

Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.

NCT06476717

Donor-derived Cell-free DNA in Kidney Transplant Recipients

NCT05914792

Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery

NCT05052671

ctDNA Assay in Patients With Resectable Pancreatic Cancer

NCT05379907

Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

NCT05170425

LAMBDA 002 (Lung Registry) Study

NCT05309382

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

NCT05081739

Donor-Derived Cell-free DNA to DETect REjection in Cardiac Transplantation

NCT05058183

Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer

NCT05837663

Trifecta-Lung cfDNA-MMDx Study

NCT06808880

EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)

NCT06620627

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

NCT06414603

A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

NCT06854939

A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.

NCT07046585

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

NCT07084558

ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness

NCT07195071

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

NCT05756088

Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA